These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 953269)

  • 1. [Different heparin fractions].
    Bychkov SM; Kharlamova VN
    Biull Eksp Biol Med; 1976 Mar; 81(3):289-91. PubMed ID: 953269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Infrared spectra of certain proteoglycans].
    Bychkov SM; Bogatov VN; Kharlamova VN
    Biull Eksp Biol Med; 1980 Jun; 89(6):680-2. PubMed ID: 7397357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for a (1 leads to 4)-linked 4-O-( -L-idopyranosyluronic acid 2-sulfate)-(2-deoxy-2-sulfoamino-D-glucopyranosyl 6-sulfate) sequence in heparin. Long-range H-H coupling in 4-deoxy-hex-4-enopyranosides.
    Perlin AS; Mackie DM; Dietrich CP
    Carbohydr Res; 1971 Jun; 18(2):185-94. PubMed ID: 5151386
    [No Abstract]   [Full Text] [Related]  

  • 4. An active fraction of unfractionated heparin from a natural source is recognized by the first component of the complement system.
    Calabrese GC; Leocatanieto F; Recondo EF; Fernandez de Recondo ME
    Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL119-23. PubMed ID: 11936856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability in the carbazole assay for N-desulfonated/N-acylated heparin derivatives.
    Hattan CM; Kerns RJ
    Carbohydr Res; 2007 Dec; 342(17):2664-9. PubMed ID: 17850773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a new potent heparin. 2nd communication: Chemical analysis of the carbohydrate content and determination of the biological activity of a new potent heparin preparation in vitro, using protamine neutralization and amidolytic methods for factor Xa and thrombin.
    Bhargava AS; Heinick J; Günzel P
    Arzneimittelforschung; 1980; 30(7):1071-4. PubMed ID: 7191289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of heparin from human mastocytoma tissue.
    Thunberg L; Höök M; Lindahl U; Abildgaard U; Langholm R
    Thromb Haemost; 1980 Dec; 44(3):125-9. PubMed ID: 6781095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on glycoproteins. IX. Kinetic studies of the chemical hydrolysis of glycoproteins. Application to ovomucoid. Hypothesis for the existence of a general scheme of structure of the carbohydrate fraction of animal glycoproteins].
    Montreuil J; Adam-Chosson A; Spik G
    Bull Soc Chim Biol (Paris); 1965; 47(10):1867-80. PubMed ID: 5882902
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study of various heparin salts].
    Bychkov SM; Bogatov VN; Kuz'mina SA
    Biull Eksp Biol Med; 1981 Dec; 92(12):680-3. PubMed ID: 7326414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a new potent heparin. 5th Communication: Further characterization by affinity chromatography on antithrombin-sepharose and its comparison with a commercially available heparin.
    Bhargava AS; Freihube G; Günzel P
    Arzneimittelforschung; 1980; 30(10):1621-3. PubMed ID: 7192096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemistry of heparin. A short review on recent chemical trends.
    Kiss J
    Thromb Diath Haemorrh; 1975 Feb; 33(1):20-5. PubMed ID: 47192
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemistry of heparin and low molecular weight heparin.
    Nielsen JI; Ostergaard P
    Acta Chir Scand Suppl; 1988; 543():52-6. PubMed ID: 2847458
    [No Abstract]   [Full Text] [Related]  

  • 13. Separation of heparin into subfractions by DEAE-cellulose chromatography.
    Yue RH; Starr T; Gertler MM
    Thromb Haemost; 1980 Feb; 42(5):1452-9. PubMed ID: 7368152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of antithrombin-protease interactions by semisynthetic low-molecular-weight heparins with different sulfation patterns.
    Sissi C; Naggi A; Torri G; Palumbo M
    Semin Thromb Hemost; 2003 Dec; 29(6):661-70. PubMed ID: 14719183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active conformations of glycosaminoglycans. NMR determination of the conformation of heparin sequences complexed with antithrombin and fibroblast growth factors in solution.
    Hricovíni M; Guerrini M; Bisio A; Torri G; Naggi A; Casu B
    Semin Thromb Hemost; 2002 Aug; 28(4):325-34. PubMed ID: 12244479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of an automated analyzer in the evaluation of antithrombin III and heparin.
    Scully MF
    Semin Thromb Hemost; 1983 Oct; 9(4):309-20. PubMed ID: 6658462
    [No Abstract]   [Full Text] [Related]  

  • 17. [Interaction of proteoglycans with proteins].
    Bychkov SM; Kuz'mina SA
    Biull Eksp Biol Med; 1986 Jun; 101(6):687-90. PubMed ID: 3730554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective N-desulfation of heparin with dimethyl sulfoxide containing water or methanol.
    Inoue Y; Nagasawa K
    Carbohydr Res; 1976 Jan; 46(1):87-95. PubMed ID: 1248016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Examination of the heterogeneity of heparin. IV. Crude heparin].
    Jarzebiński J; Gryz K; Tońska S
    Acta Pol Pharm; 1993; 50(2-3):127-9. PubMed ID: 8030421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycosaminoglycans of human urine. 3. Isolation and characterization of urinary glycosaminoglycans in normal and kwashiorkor children.
    Cherian R; Chandrasekaran EV; Bachhawat BK
    Indian J Biochem; 1970 Sep; 7(3):174-7. PubMed ID: 4252572
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.